img

Global HIV Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global HIV Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
HIV Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global HIV Therapy market is projected to reach US$ 3952.5 million in 2029, increasing from US$ 3040 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for HIV Therapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, HIV Therapy key manufacturers include ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc., etc. ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc are top 3 players and held % sales share in total in 2022.
HIV Therapy can be divided into Integrase Inhibitors, Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Combination HIV Medicines and Others, etc. Integrase Inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022.
HIV Therapy is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others, etc. Hospital Pharmacies provides greatest supports to the HIV Therapy industry development. In 2022, global % sales of HIV Therapy went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global HIV Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ViiV Healthcare
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Merck Sharp & Dohme Corp.
Bristol-Myers Squibb Company
Janssen Pharmaceuticals, Inc.
Boehringer Ingelheim International GmbH
AbbVie Inc.
Genentech, Inc.
Mylan N.V.
Segment by Type
Integrase Inhibitors
Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Combination HIV Medicines
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the HIV Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of HIV Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the HIV Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of HIV Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, HIV Therapy introduction, etc. HIV Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of HIV Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 HIV Therapy Market Overview
1.1 HIV Therapy Product Overview
1.2 HIV Therapy Market Segment by Type
1.2.1 Integrase Inhibitors
1.2.2 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
1.2.3 Combination HIV Medicines
1.2.4 Others
1.3 Global HIV Therapy Market Size by Type
1.3.1 Global HIV Therapy Market Size Overview by Type (2018-2029)
1.3.2 Global HIV Therapy Historic Market Size Review by Type (2018-2024)
1.3.3 Global HIV Therapy Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America HIV Therapy Sales Breakdown by Type (2018-2024)
1.4.2 Europe HIV Therapy Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific HIV Therapy Sales Breakdown by Type (2018-2024)
1.4.4 Latin America HIV Therapy Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa HIV Therapy Sales Breakdown by Type (2018-2024)
2 Global HIV Therapy Market Competition by Company
2.1 Global Top Players by HIV Therapy Sales (2018-2024)
2.2 Global Top Players by HIV Therapy Revenue (2018-2024)
2.3 Global Top Players by HIV Therapy Price (2018-2024)
2.4 Global Top Manufacturers HIV Therapy Manufacturing Base Distribution, Sales Area, Product Type
2.5 HIV Therapy Market Competitive Situation and Trends
2.5.1 HIV Therapy Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by HIV Therapy Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Therapy as of 2022)
2.7 Date of Key Manufacturers Enter into HIV Therapy Market
2.8 Key Manufacturers HIV Therapy Product Offered
2.9 Mergers & Acquisitions, Expansion
3 HIV Therapy Status and Outlook by Region
3.1 Global HIV Therapy Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global HIV Therapy Historic Market Size by Region
3.2.1 Global HIV Therapy Sales in Volume by Region (2018-2024)
3.2.2 Global HIV Therapy Sales in Value by Region (2018-2024)
3.2.3 Global HIV Therapy Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global HIV Therapy Forecasted Market Size by Region
3.3.1 Global HIV Therapy Sales in Volume by Region (2024-2029)
3.3.2 Global HIV Therapy Sales in Value by Region (2024-2029)
3.3.3 Global HIV Therapy Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global HIV Therapy by Application
4.1 HIV Therapy Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.1.4 Others
4.2 Global HIV Therapy Market Size by Application
4.2.1 Global HIV Therapy Market Size Overview by Application (2018-2029)
4.2.2 Global HIV Therapy Historic Market Size Review by Application (2018-2024)
4.2.3 Global HIV Therapy Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America HIV Therapy Sales Breakdown by Application (2018-2024)
4.3.2 Europe HIV Therapy Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific HIV Therapy Sales Breakdown by Application (2018-2024)
4.3.4 Latin America HIV Therapy Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa HIV Therapy Sales Breakdown by Application (2018-2024)
5 North America HIV Therapy by Country
5.1 North America HIV Therapy Historic Market Size by Country
5.1.1 North America HIV Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America HIV Therapy Sales in Volume by Country (2018-2024)
5.1.3 North America HIV Therapy Sales in Value by Country (2018-2024)
5.2 North America HIV Therapy Forecasted Market Size by Country
5.2.1 North America HIV Therapy Sales in Volume by Country (2024-2029)
5.2.2 North America HIV Therapy Sales in Value by Country (2024-2029)
6 Europe HIV Therapy by Country
6.1 Europe HIV Therapy Historic Market Size by Country
6.1.1 Europe HIV Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe HIV Therapy Sales in Volume by Country (2018-2024)
6.1.3 Europe HIV Therapy Sales in Value by Country (2018-2024)
6.2 Europe HIV Therapy Forecasted Market Size by Country
6.2.1 Europe HIV Therapy Sales in Volume by Country (2024-2029)
6.2.2 Europe HIV Therapy Sales in Value by Country (2024-2029)
7 Asia-Pacific HIV Therapy by Region
7.1 Asia-Pacific HIV Therapy Historic Market Size by Region
7.1.1 Asia-Pacific HIV Therapy Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific HIV Therapy Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific HIV Therapy Sales in Value by Region (2018-2024)
7.2 Asia-Pacific HIV Therapy Forecasted Market Size by Region
7.2.1 Asia-Pacific HIV Therapy Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific HIV Therapy Sales in Value by Region (2024-2029)
8 Latin America HIV Therapy by Country
8.1 Latin America HIV Therapy Historic Market Size by Country
8.1.1 Latin America HIV Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America HIV Therapy Sales in Volume by Country (2018-2024)
8.1.3 Latin America HIV Therapy Sales in Value by Country (2018-2024)
8.2 Latin America HIV Therapy Forecasted Market Size by Country
8.2.1 Latin America HIV Therapy Sales in Volume by Country (2024-2029)
8.2.2 Latin America HIV Therapy Sales in Value by Country (2024-2029)
9 Middle East and Africa HIV Therapy by Country
9.1 Middle East and Africa HIV Therapy Historic Market Size by Country
9.1.1 Middle East and Africa HIV Therapy Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa HIV Therapy Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa HIV Therapy Sales in Value by Country (2018-2024)
9.2 Middle East and Africa HIV Therapy Forecasted Market Size by Country
9.2.1 Middle East and Africa HIV Therapy Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa HIV Therapy Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 ViiV Healthcare
10.1.1 ViiV Healthcare Company Information
10.1.2 ViiV Healthcare Introduction and Business Overview
10.1.3 ViiV Healthcare HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.1.4 ViiV Healthcare HIV Therapy Products Offered
10.1.5 ViiV Healthcare Recent Development
10.2 Gilead Sciences, Inc.
10.2.1 Gilead Sciences, Inc. Company Information
10.2.2 Gilead Sciences, Inc. Introduction and Business Overview
10.2.3 Gilead Sciences, Inc. HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Gilead Sciences, Inc. HIV Therapy Products Offered
10.2.5 Gilead Sciences, Inc. Recent Development
10.3 GlaxoSmithKline Plc
10.3.1 GlaxoSmithKline Plc Company Information
10.3.2 GlaxoSmithKline Plc Introduction and Business Overview
10.3.3 GlaxoSmithKline Plc HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GlaxoSmithKline Plc HIV Therapy Products Offered
10.3.5 GlaxoSmithKline Plc Recent Development
10.4 Merck Sharp & Dohme Corp.
10.4.1 Merck Sharp & Dohme Corp. Company Information
10.4.2 Merck Sharp & Dohme Corp. Introduction and Business Overview
10.4.3 Merck Sharp & Dohme Corp. HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Sharp & Dohme Corp. HIV Therapy Products Offered
10.4.5 Merck Sharp & Dohme Corp. Recent Development
10.5 Bristol-Myers Squibb Company
10.5.1 Bristol-Myers Squibb Company Company Information
10.5.2 Bristol-Myers Squibb Company Introduction and Business Overview
10.5.3 Bristol-Myers Squibb Company HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bristol-Myers Squibb Company HIV Therapy Products Offered
10.5.5 Bristol-Myers Squibb Company Recent Development
10.6 Janssen Pharmaceuticals, Inc.
10.6.1 Janssen Pharmaceuticals, Inc. Company Information
10.6.2 Janssen Pharmaceuticals, Inc. Introduction and Business Overview
10.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Janssen Pharmaceuticals, Inc. HIV Therapy Products Offered
10.6.5 Janssen Pharmaceuticals, Inc. Recent Development
10.7 Boehringer Ingelheim International GmbH
10.7.1 Boehringer Ingelheim International GmbH Company Information
10.7.2 Boehringer Ingelheim International GmbH Introduction and Business Overview
10.7.3 Boehringer Ingelheim International GmbH HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Boehringer Ingelheim International GmbH HIV Therapy Products Offered
10.7.5 Boehringer Ingelheim International GmbH Recent Development
10.8 AbbVie Inc.
10.8.1 AbbVie Inc. Company Information
10.8.2 AbbVie Inc. Introduction and Business Overview
10.8.3 AbbVie Inc. HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.8.4 AbbVie Inc. HIV Therapy Products Offered
10.8.5 AbbVie Inc. Recent Development
10.9 Genentech, Inc.
10.9.1 Genentech, Inc. Company Information
10.9.2 Genentech, Inc. Introduction and Business Overview
10.9.3 Genentech, Inc. HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Genentech, Inc. HIV Therapy Products Offered
10.9.5 Genentech, Inc. Recent Development
10.10 Mylan N.V.
10.10.1 Mylan N.V. Company Information
10.10.2 Mylan N.V. Introduction and Business Overview
10.10.3 Mylan N.V. HIV Therapy Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mylan N.V. HIV Therapy Products Offered
10.10.5 Mylan N.V. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 HIV Therapy Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 HIV Therapy Industrial Chain Analysis
11.4 HIV Therapy Market Dynamics
11.4.1 HIV Therapy Industry Trends
11.4.2 HIV Therapy Market Drivers
11.4.3 HIV Therapy Market Challenges
11.4.4 HIV Therapy Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 HIV Therapy Distributors
12.3 HIV Therapy Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Integrase Inhibitors
Table 2. Major Company of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Table 3. Major Company of Combination HIV Medicines
Table 4. Major Company of Others
Table 5. Global HIV Therapy Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 7. Global HIV Therapy Sales Market Share in Volume by Type (2018-2024)
Table 8. Global HIV Therapy Sales by Type (2018-2024) & (US& Million)
Table 9. Global HIV Therapy Market Share in Value by Type (2018-2024)
Table 10. Global HIV Therapy Price by Type (2018-2024) & (US$/Unit)
Table 11. Global HIV Therapy Sales by Type (2024-2029) & (K Units)
Table 12. Global HIV Therapy Sales Market Share in Volume by Type (2024-2029)
Table 13. Global HIV Therapy Sales by Type (2024-2029) & (US$ Million)
Table 14. Global HIV Therapy Sales Market Share in Value by Type (2024-2029)
Table 15. Global HIV Therapy Price by Type (2024-2029) & (US$/Unit)
Table 16. North America HIV Therapy Sales by Type (2018-2024) & (K Units)
Table 17. North America HIV Therapy Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe HIV Therapy Sales (K Units) by Type (2018-2024)
Table 19. Europe HIV Therapy Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific HIV Therapy Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific HIV Therapy Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America HIV Therapy Sales (K Units) by Type (2018-2024)
Table 23. Latin America HIV Therapy Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa HIV Therapy Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa HIV Therapy Sales by Type (2018-2024) & (US$ Million)
Table 26. Global HIV Therapy Sales by Company (2018-2024) & (K Units)
Table 27. Global HIV Therapy Sales Share by Company (2018-2024)
Table 28. Global HIV Therapy Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global HIV Therapy Revenue Share by Company (2018-2024)
Table 30. Global Market HIV Therapy Price by Company (2018-2024) & (US$/Unit)
Table 31. Global HIV Therapy Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global HIV Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Therapy as of 2022)
Table 34. Date of Key Manufacturers Enter into HIV Therapy Market
Table 35. Key Manufacturers HIV Therapy Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global HIV Therapy Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global HIV Therapy Sales by Region (2018-2024) & (K Units)
Table 39. Global HIV Therapy Sales Market Share in Volume by Region (2018-2024)
Table 40. Global HIV Therapy Sales by Region (2018-2024) & (US$ Million)
Table 41. Global HIV Therapy Sales Market Share in Value by Region (2018-2024)
Table 42. Global HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global HIV Therapy Sales by Region (2024-2029) & (K Units)
Table 44. Global HIV Therapy Sales Market Share in Volume by Region (2024-2029)
Table 45. Global HIV Therapy Sales by Region (2024-2029) & (US$ Million)
Table 46. Global HIV Therapy Sales Market Share in Value by Region (2024-2029)
Table 47. Global HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global HIV Therapy Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global HIV Therapy Sales by Application (2018-2024) & (K Units)
Table 50. Global HIV Therapy Sales Market Share in Volume by Application (2018-2024)
Table 51. Global HIV Therapy Sales by Application (2018-2024) & (US$ Million)
Table 52. Global HIV Therapy Sales Market Share in Value by Application (2018-2024)
Table 53. Global HIV Therapy Price by Application (2018-2024) & (US$/Unit)
Table 54. Global HIV Therapy Sales by Application (2024-2029) & (K Units)
Table 55. Global HIV Therapy Sales Market Share in Volume by Application (2024-2029)
Table 56. Global HIV Therapy Sales by Application (2024-2029) & (US$ Million)
Table 57. Global HIV Therapy Sales Market Share in Value by Application (2024-2029)
Table 58. Global HIV Therapy Price by Application (2024-2029) & (US$/Unit)
Table 59. North America HIV Therapy Sales by Application (2018-2024) (K Units)
Table 60. North America HIV Therapy Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe HIV Therapy Sales by Application (2018-2024) (K Units)
Table 62. Europe HIV Therapy Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific HIV Therapy Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific HIV Therapy Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America HIV Therapy Sales by Application (2018-2024) (K Units)
Table 66. Latin America HIV Therapy Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa HIV Therapy Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa HIV Therapy Sales by Application (2018-2024) & (US$ Million)
Table 69. North America HIV Therapy Sales by Country (2018-2024) & (K Units)
Table 70. North America HIV Therapy Sales Market Share in Volume by Country (2018-2024)
Table 71. North America HIV Therapy Sales by Country (2018-2024) & (US$ Million)
Table 72. North America HIV Therapy Sales Market Share in Value by Country (2018-2024)
Table 73. North America HIV Therapy Sales by Country (2024-2029) & (K Units)
Table 74. North America HIV Therapy Sales Market Share in Volume by Country (2024-2029)
Table 75. North America HIV Therapy Sales by Country (2024-2029) & (US$ Million)
Table 76. North America HIV Therapy Sales Market Share in Value by Country (2024-2029)
Table 77. Europe HIV Therapy Sales by Country (2018-2024) & (K Units)
Table 78. Europe HIV Therapy Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe HIV Therapy Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe HIV Therapy Sales Market Share in Value by Country (2018-2024)
Table 81. Europe HIV Therapy Sales by Country (2024-2029) & (K Units)
Table 82. Europe HIV Therapy Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe HIV Therapy Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe HIV Therapy Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific HIV Therapy Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific HIV Therapy Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific HIV Therapy Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific HIV Therapy Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific HIV Therapy Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific HIV Therapy Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific HIV Therapy Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific HIV Therapy Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America HIV Therapy Sales by Country (2018-2024) & (K Units)
Table 94. Latin America HIV Therapy Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America HIV Therapy Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America HIV Therapy Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America HIV Therapy Sales by Country (2024-2029) & (K Units)
Table 98. Latin America HIV Therapy Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America HIV Therapy Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America HIV Therapy Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa HIV Therapy Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa HIV Therapy Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa HIV Therapy Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa HIV Therapy Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa HIV Therapy Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa HIV Therapy Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa HIV Therapy Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa HIV Therapy Sales Market Share in Value by Country (2024-2029)
Table 109. ViiV Healthcare Company Information
Table 110. ViiV Healthcare Introduction and Business Overview
Table 111. ViiV Healthcare HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. ViiV Healthcare HIV Therapy Product
Table 113. ViiV Healthcare Recent Development
Table 114. Gilead Sciences, Inc. Company Information
Table 115. Gilead Sciences, Inc. Introduction and Business Overview
Table 116. Gilead Sciences, Inc. HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Gilead Sciences, Inc. HIV Therapy Product
Table 118. Gilead Sciences, Inc. Recent Development
Table 119. GlaxoSmithKline Plc Company Information
Table 120. GlaxoSmithKline Plc Introduction and Business Overview
Table 121. GlaxoSmithKline Plc HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. GlaxoSmithKline Plc HIV Therapy Product
Table 123. GlaxoSmithKline Plc Recent Development
Table 124. Merck Sharp & Dohme Corp. Company Information
Table 125. Merck Sharp & Dohme Corp. Introduction and Business Overview
Table 126. Merck Sharp & Dohme Corp. HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Merck Sharp & Dohme Corp. HIV Therapy Product
Table 128. Merck Sharp & Dohme Corp. Recent Development
Table 129. Bristol-Myers Squibb Company Company Information
Table 130. Bristol-Myers Squibb Company Introduction and Business Overview
Table 131. Bristol-Myers Squibb Company HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Bristol-Myers Squibb Company HIV Therapy Product
Table 133. Bristol-Myers Squibb Company Recent Development
Table 134. Janssen Pharmaceuticals, Inc. Company Information
Table 135. Janssen Pharmaceuticals, Inc. Introduction and Business Overview
Table 136. Janssen Pharmaceuticals, Inc. HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Janssen Pharmaceuticals, Inc. HIV Therapy Product
Table 138. Janssen Pharmaceuticals, Inc. Recent Development
Table 139. Boehringer Ingelheim International GmbH Company Information
Table 140. Boehringer Ingelheim International GmbH Introduction and Business Overview
Table 141. Boehringer Ingelheim International GmbH HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Boehringer Ingelheim International GmbH HIV Therapy Product
Table 143. Boehringer Ingelheim International GmbH Recent Development
Table 144. AbbVie Inc. Company Information
Table 145. AbbVie Inc. Introduction and Business Overview
Table 146. AbbVie Inc. HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. AbbVie Inc. HIV Therapy Product
Table 148. AbbVie Inc. Recent Development
Table 149. Genentech, Inc. Company Information
Table 150. Genentech, Inc. Introduction and Business Overview
Table 151. Genentech, Inc. HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Genentech, Inc. HIV Therapy Product
Table 153. Genentech, Inc. Recent Development
Table 154. Mylan N.V. Company Information
Table 155. Mylan N.V. Introduction and Business Overview
Table 156. Mylan N.V. HIV Therapy Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Mylan N.V. HIV Therapy Product
Table 158. Mylan N.V. Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. HIV Therapy Market Trends
Table 162. HIV Therapy Market Drivers
Table 163. HIV Therapy Market Challenges
Table 164. HIV Therapy Market Restraints
Table 165. HIV Therapy Distributors List
Table 166. HIV Therapy Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV Therapy Product Picture
Figure 2. Global HIV Therapy Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global HIV Therapy Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global HIV Therapy Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Integrase Inhibitors
Figure 6. Global Integrase Inhibitors Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Figure 8. Global Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Combination HIV Medicines
Figure 10. Global Combination HIV Medicines Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global HIV Therapy Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global HIV Therapy Sales Market Share by Type in 2022 & 2029
Figure 15. North America HIV Therapy Sales Market Share in Volume by Type in 2022
Figure 16. North America HIV Therapy Sales Market Share in Value by Type in 2022
Figure 17. Europe HIV Therapy Sales Market Share in Volume by Type in 2022
Figure 18. Europe HIV Therapy Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific HIV Therapy Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific HIV Therapy Sales Market Share in Value by Type in 2022
Figure 21. Latin America HIV Therapy Sales Market Share in Volume by Type in 2022
Figure 22. Latin America HIV Therapy Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa HIV Therapy Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa HIV Therapy Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by HIV Therapy Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by HIV Therapy Revenue in 2022
Figure 27. HIV Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Global Hospital Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Retail Pharmacies
Figure 31. Global Retail Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Online Pharmacies
Figure 33. Global Online Pharmacies Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global HIV Therapy Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global HIV Therapy Sales Market Share by Application in 2022 & 2029
Figure 38. North America HIV Therapy Sales Market Share in Volume by Application in 2022
Figure 39. North America HIV Therapy Sales Market Share in Value by Application in 2022
Figure 40. Europe HIV Therapy Sales Market Share in Volume by Application in 2022
Figure 41. Europe HIV Therapy Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific HIV Therapy Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific HIV Therapy Sales Market Share in Value by Application in 2022
Figure 44. Latin America HIV Therapy Sales Market Share in Volume by Application in 2022
Figure 45. Latin America HIV Therapy Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa HIV Therapy Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. HIV Therapy Manufacturing Cost Structure
Figure 49. HIV Therapy Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries